167 related articles for article (PubMed ID: 12239154)
1. Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera.
Klippel S; Strunck E; Busse CE; Behringer D; Pahl HL
Blood; 2002 Oct; 100(7):2441-8. PubMed ID: 12239154
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of PRV-1 gene in polycythemia rubra vera and essential thrombocythemia.
Martini M; Teofili L; Larocca LM
Methods Mol Med; 2006; 125():265-73. PubMed ID: 16502591
[TBL] [Abstract][Full Text] [Related]
3. The gene overexpressed in polycythemia rubra vera, PRV-1, and the gene encoding a neutrophil alloantigen, NB1, are alleles of a single gene, CD177, in chromosome band 19q13.31.
Caruccio L; Bettinotti M; Director-Myska AE; Arthur DC; Stroncek D
Transfusion; 2006 Mar; 46(3):441-7. PubMed ID: 16533288
[TBL] [Abstract][Full Text] [Related]
4. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera.
Temerinac S; Klippel S; Strunck E; Röder S; Lübbert M; Lange W; Azemar M; Meinhardt G; Schaefer HE; Pahl HL
Blood; 2000 Apr; 95(8):2569-76. PubMed ID: 10753836
[TBL] [Abstract][Full Text] [Related]
5. PRV-1 mRNA expression and other molecular markers in polycythemia rubra vera.
Pahl HL
Curr Hematol Rep; 2003 May; 2(3):231-6. PubMed ID: 12901344
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization analysis of the PRV-1 gene in polycythemia vera: implications for its role in diagnosis and pathogenesis.
Najfeld V; Fuchs S; Merando P; Lezon-Geyda K; Fruchtman S
Exp Hematol; 2003 Feb; 31(2):118-21. PubMed ID: 12591276
[TBL] [Abstract][Full Text] [Related]
7. Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis.
Klippel S; Strunck E; Temerinac S; Bench AJ; Meinhardt G; Mohr U; Leichtle R; Green AR; Griesshammer M; Heimpel H; Pahl HL
Blood; 2003 Nov; 102(10):3569-74. PubMed ID: 12893745
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia.
Teofili L; Martini M; Luongo M; Di Mario A; Leone G; De Stefano V; Larocca LM
J Clin Oncol; 2002 Oct; 20(20):4249-54. PubMed ID: 12377969
[TBL] [Abstract][Full Text] [Related]
9. The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow cells and does not discriminate polycythaemia vera from reactive and other chronic myeloproliferative disorders.
Bock O; Serinsöz E; Neusch M; Schlué J; Kreipe H
Br J Haematol; 2003 Nov; 123(3):472-4. PubMed ID: 14617008
[TBL] [Abstract][Full Text] [Related]
10. PRV-1 mRNA expression discriminates two types of essential thrombocythemia.
Griesshammer M; Klippel S; Strunck E; Temerinac S; Mohr U; Heimpel H; Pahl HL
Ann Hematol; 2004 Jun; 83(6):364-70. PubMed ID: 15034760
[TBL] [Abstract][Full Text] [Related]
11. CD177 polymorphisms: correlation between high-frequency single nucleotide polymorphisms and neutrophil surface protein expression.
Caruccio L; Walkovich K; Bettinotti M; Schuller R; Stroncek D
Transfusion; 2004 Jan; 44(1):77-82. PubMed ID: 14692971
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia.
Tefferi A; Lasho TL; Wolanskyj AP; Mesa RA
Blood; 2004 May; 103(9):3547-8. PubMed ID: 14701686
[TBL] [Abstract][Full Text] [Related]
13. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM
J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568
[TBL] [Abstract][Full Text] [Related]
14. Instability of PRV-1 mRNA: a factor to be considered in PRV-1 quantification for the diagnosis of polycythemia vera.
Jelinek J; Jedlickova K; Guan Y; Prchal JT
Haematologica; 2004 Jun; 89(6):749-51. PubMed ID: 15194544
[TBL] [Abstract][Full Text] [Related]
15. Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.
Tutaeva V; Misurin AV; Michiels JJ; Rozenberg JM; Sokolova MA; Ivanova VL; Kolosheinova TI; Manakova TE; Levina AA; Semenova EA; Khoroshko ND
Hematology; 2007 Dec; 12(6):473-9. PubMed ID: 17852451
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic approaches to polycythemia vera in 2004.
Pahl HL
Expert Rev Mol Diagn; 2004 Jul; 4(4):495-502. PubMed ID: 15225097
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic control of PRV-1 expression on neutrophils.
Jelinek J; Li J; Mnjoyan Z; Issa JP; Prchal JT; Afshar-Kharghan V
Exp Hematol; 2007 Nov; 35(11):1677-83. PubMed ID: 17976520
[TBL] [Abstract][Full Text] [Related]
18. Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia.
Tefferi A; Sirhan S; Lasho TL; Schwager SM; Li CY; Dingli D; Wolanskyj AP; Steensma DP; Mesa R; Gilliland DG
Br J Haematol; 2005 Oct; 131(2):166-71. PubMed ID: 16197445
[TBL] [Abstract][Full Text] [Related]
19. Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia.
Florensa L; Besses C; Zamora L; Bellosillo B; Espinet B; Serrano S; Woessner S; Solé F
Blood; 2004 Mar; 103(6):2427-8. PubMed ID: 14998917
[No Abstract] [Full Text] [Related]
20. PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia.
Passamonti F; Pietra D; Rumi E; Arcaini L; Della Porta MG; Malcovati L; Pascutto C; Lazzarino M; Cazzola M
Leukemia; 2005 May; 19(5):888-9. PubMed ID: 15744342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
